Physician profile
Eric Colton
NPI 1790723492
$3,949.43
in general payments reported to CMS, 2019-2025
9 companies · $2,582 in 2025
The $2,582 reported for 2025 was more than what 95% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $358 · 2022: $22.04 · 2023: $771 · 2024: $217 · 2025: $2,582.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $1,662 · Consulting Fee: $1,563 · Food and Beverage: $345.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $1,662.00 |
| Consulting Fee | $1,562.84 |
| Food and Beverage | $344.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $1,993.32 | 2022-2025 | Jada System |
| Olympus Winter & Ibe Gmbh | $875.00 | 2025 | Endoeye Flex Deflectable Videoscope |
| Cepheid | $350.00 | 2021 | |
| Medtronic, INC. | $254.17 | 2023 | |
| Dr.Reddy'S Laboratories,INC. | $217.00 | 2023 | |
| Becton, Dickinson and Company | $216.67 | 2024 | |
| Galderma Laboratories, L.P. | $18.29 | 2025 | |
| Smith+Nephew, INC. | $17.12 | 2022 | |
| Alydia Health | $7.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Colton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.